Article Text

SAT0140 Recommendations for Investigating and Managing Comorbidity in Rheumatoid Arthritis
  1. E. Loza1,
  2. C. Lajas2,
  3. J.L. Andreu3,
  4. A. Balsa4,
  5. I. Gonzalez-Alvaro5,
  6. O. Illera6,
  7. J.A. Jover2,
  8. I. Mateo7,
  9. J. Orte8,
  10. J. Rivera9,
  11. J.M. Rodríguez Heredia10,
  12. F. Romero11,
  13. J.A. Martínez Lόpez11,
  14. A.M. Ortiz5,
  15. E. Toledano2,
  16. V. Villaverde12,
  17. L. Carmona1,
  18. S. Castañeda5
  19. on behalf of GECOAR Study Group
  1. 1InMusc
  2. 2H. Clínico San Carlos
  3. 3H. Puerta de Hierro
  4. 4H. La Paz
  5. 5H. de la Princesa
  6. 6H. Infanta Sofía
  7. 7H. 12 de Octubre
  8. 8H. Ramon y Cajal
  9. 9Instituto Provincial de Rehabilitaciόn
  10. 10H. de Getafe
  11. 11Fundaciόn Jiménez Díaz
  12. 12H. de Mόstoles, Madrid, Spain


Objectives To develop evidence-based recommendations for the detection and management of comorbidity in rheumatoid arthritis (RA) in daily practice.

Methods We used a modified RAND/UCLA methodology and systematic review. Discussion groups established recommendations, which were prioritized, refined, and graded in a large group of users by a 2-round Delphi survey.

Results The first 9/21 recommendations with agreement (A), and level of evidence (LE) are listed in Table 1.

Table 1

Conclusions We established recommendations that cover what, how, when and by whom to investigate and manage comorbidity in RA. Additional materials, such as tables and checklists, will facilitate their implementation.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.3089

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.